![Ramkumar Mandalam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ramkumar Mandalam
Directeur/Bestuurslid bij CRYOPORT, INC.
Vermogen: 576 009 $ op 31-05-2024
Actieve functies van Ramkumar Mandalam
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CRYOPORT, INC. | Directeur/Bestuurslid | 16-06-2014 | - |
Independent Dir/Board Member | 16-06-2014 | - | |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Directeur/Bestuurslid | 20-10-2010 | - |
Algemeen Directeur | 01-01-2005 | - | |
President | 01-01-2005 | - | |
Stempeutics Research Pvt. Ltd.
![]() Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Directeur/Bestuurslid | - | - |
Citra Bioconsulting, Inc. | Algemeen Directeur | 01-01-2021 | - |
Oprichter | 01-01-2021 | - |
Loopbaan van Ramkumar Mandalam
Eerdere bekende functies van Ramkumar Mandalam
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VERICEL CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-01-1994 | 01-01-2000 |
Corporate Officer/Principal | 01-01-1994 | 01-01-2000 | |
GERON CORPORATION | Corporate Officer/Principal | - | - |
Opleiding van Ramkumar Mandalam
University of Michigan | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
India | 2 |
Operationeel
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Transportation | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
GERON CORPORATION | Health Technology |
VERICEL CORPORATION | Health Technology |
CRYOPORT, INC. | Transportation |
Bedrijven in privébezit | 3 |
---|---|
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Stempeutics Research Pvt. Ltd.
![]() Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Health Technology |
Citra Bioconsulting, Inc. |
- Beurs
- Insiders
- Ramkumar Mandalam
- Ervaring